Published in Infect Immun on March 01, 1986
Clinical protection from falciparum malaria correlates with neutrophil respiratory bursts induced by merozoites opsonized with human serum antibodies. PLoS One (2010) 1.46
Tumor necrosis factor enhances neutrophil-mediated killing of Plasmodium falciparum. Infect Immun (1990) 1.28
Killing of Plasmodium falciparum by eosinophil secretory products. Infect Immun (1987) 1.01
Neutrophils interact with adenovirus vectors via Fc receptors and complement receptor 1. J Virol (2005) 1.00
Leukocytes in a Plasmodium falciparum-infected blood meal reduce transmission of malaria to Anopheles mosquitoes. Infect Immun (1997) 0.99
Effects of amodiaquine, chloroquine, and mefloquine on human polymorphonuclear neutrophil function in vitro. Antimicrob Agents Chemother (1988) 0.99
Complement activation in Ghanaian children with severe Plasmodium falciparum malaria. Malar J (2007) 0.97
Complement contributes to protective immunity against reinfection by Plasmodium chabaudi chabaudi parasites. Infect Immun (2001) 0.94
Opsonization and phagocytosis of Plasmodium falciparum merozoites measured by flow cytometry. Clin Diagn Lab Immunol (2000) 0.92
Mechanisms of stage-transcending protection following immunization of mice with late liver stage-arresting genetically attenuated malaria parasites. PLoS Pathog (2015) 0.90
Phagocyte-derived reactive oxygen species do not influence the progression of murine blood-stage malaria infections. Infect Immun (2005) 0.88
Susceptibility of Plasmodium falciparum to a peroxidase-mediated oxygen-dependent microbicidal system. Infect Immun (1988) 0.83
Antibodies to Plasmodium falciparum merozoite surface protein-1p19 malaria vaccine candidate induce antibody-dependent respiratory burst in human neutrophils. Malar J (2015) 0.77
Functions of Antibodies. Microbiol Spectr (2014) 0.75
Human malaria parasites in continuous culture. Science (1976) 59.70
C3 shunt activation in human serum chelated with EGTA. J Immunol (1972) 6.94
The role of membrane receptors for C3b and C3d in phagocytosis. J Exp Med (1977) 6.19
Concentration from continuous culture of erythrocytes infected with trophozoites and schizonts of Plasmodium falciparum. Am J Trop Med Hyg (1978) 3.46
The origin of the chemiluminescence of phagocytosing granulocytes. J Clin Invest (1976) 2.92
Malaria (Plasmodium knowlesi) merozoites: immunity and the surface coat. J Immunol (1975) 2.86
Evidence for reactive oxygen intermediates causing hemolysis and parasite death in malaria. Infect Immun (1983) 2.59
Association between human serum-induced crisis forms in cultured Plasmodium falciparum and clinical immunity to malaria in Sudan. Infect Immun (1983) 2.08
The role of cell-mediated immune responses in resistance to malaria, with special reference to oxidant stress. Annu Rev Immunol (1983) 1.88
Oxidant damage mediates variant red cell resistance to malaria. Nature (1979) 1.85
Polymorphonuclear leukocyte-mediated, antibody-dependent, cellular cytotoxicity against tumor cells: dependence on oxygen and the respiratory burst. J Immunol (1979) 1.81
Killing of blood-stage murine malaria parasites by hydrogen peroxide. Infect Immun (1983) 1.74
Indirect fluorescent-antibody tests for parasitic diseases. V. An evaluation of a thick-smear antigen in the IFA test for malaria antibodies. Am J Trop Med Hyg (1969) 1.61
Plasmodium berghei: adherence and phagocytosis by rat macrophages in vitro. Exp Parasitol (1972) 1.57
Plasmodium falciparum: phagocytosis by polymorphonuclear leukocytes. Science (1968) 1.51
Enhanced Plasmodium falciparum merozoite phagocytosis by monocytes from immune individuals. Infect Immun (1982) 1.46
A radical interpretation of immunity to malaria parasites. Lancet (1982) 1.46
Complement activation in children with acute malaria. Clin Exp Immunol (1974) 1.37
Phagocytosis of Plasmodium falciparum-parasitized erythrocytes by human polymorphonuclear leukocytes. J Parasitol (1983) 1.26
Inhibition of the in vitro growth of Plasmodium falciparum by human polymorphonuclear neutrophil leucocytes. Clin Exp Immunol (1981) 1.24
Antibody-dependent ingestion of P. falciparum merozoites by human blood monocytes. Parasite Immunol (1983) 1.12
Enhanced inhibition of in vitro multiplication of Plasmodium falciparum by stimulated human polymorphonuclear leucocytes. Clin Exp Immunol (1984) 1.09
Human toxic neutrophils. 3. Metabolic characteristics. J Infect Dis (1973) 1.03
Serum opsonic activity in rodent malaria: functional and immunochemical characteristics in vitro. J Immunol (1979) 1.02
Immune phagocytosis of Plasmodium yoelii-infected erythrocytes by macrophages and eosinophils. Clin Exp Immunol (1980) 0.99
Chemiluminescence response of peritoneal macrophages to parasitized erythrocytes and lysed erythrocytes from Plasmodium berghei-infected mice. Infect Immun (1982) 0.96
Production of luminol-reactive oxygen radicals during Plasmodium vinckei infection. Infect Immun (1984) 0.89
The determination of leukocyte phagocytic oxidase activity by measurement of the initial rate of stimulated oxygen consumption. J Lab Clin Med (1975) 0.79
Serum CH50 and C'3 levels in malaria. Indian J Med Res (1982) 0.78
Effects of immune and hyperimmune serum on the dynamics of phagocytosis of Plasmodium berghei-infected erythrocytes. Rev Inst Med Trop Sao Paulo (1983) 0.77
Functional-structural plant modelling: a new versatile tool in crop science. J Exp Bot (2009) 4.98
Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proc Natl Acad Sci U S A (1999) 4.52
The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity. Neurology (1990) 3.79
The prevalence of dementia and Alzheimer's disease in Shanghai, China: impact of age, gender, and education. Ann Neurol (1990) 3.57
Immunocapture diagnostic assays for malaria using Plasmodium lactate dehydrogenase (pLDH). Am J Trop Med Hyg (1999) 3.03
Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registry. Arthritis Rheum (2009) 2.92
Activities of clarithromycin, sulfisoxazole, and rifabutin against Mycobacterium avium complex multiplication within human macrophages. Antimicrob Agents Chemother (1990) 2.46
The genes and transcripts of an antigen gene expression site from T. brucei. Cell (1989) 2.36
Long-term results of monthly inhaled pentamidine as primary prophylaxis of Pneumocystis carinii pneumonia in HIV-infected patients. Am J Med (1993) 2.02
[Does a probability of paternity exist?]. Med Leg Dommage Corpor (1972) 1.99
The incidence of AIDS-defining illnesses at a current CD4 count ≥ 200 cells/μL in the post-combination antiretroviral therapy era. Clin Infect Dis (2013) 1.91
Activities of sparfloxacin, azithromycin, temafloxacin, and rifapentine compared with that of clarithromycin against multiplication of Mycobacterium avium complex within human macrophages. Antimicrob Agents Chemother (1991) 1.77
Report of the task force on designing clinical trials in early (predementia) AD. Neurology (2010) 1.75
Failure to maintain long-term adherence to highly active antiretroviral therapy: the role of lipodystrophy. AIDS (2001) 1.63
Evaluation of teicoplanin for treatment of endocarditis caused by gram-positive cocci in 20 patients. Antimicrob Agents Chemother (1989) 1.62
Role of IgG and complement component C5 in the initial course of experimental cryptococcosis. Clin Exp Immunol (1989) 1.55
Measurement of the forward-backward charge asymmetry in top-quark pair production. Phys Rev Lett (2008) 1.53
Clinical and bacterial features of infections caused by Streptococcus milleri. Scand J Infect Dis (1991) 1.51
Detection and quantification of HIV-1 in semen: identification of a subpopulation of men at high potential risk of viral sexual transmission. AIDS (1999) 1.51
A functional-structural model of elongation of the grass leaf and its relationships with the phyllochron. New Phytol (2005) 1.46
Tumor necrosis factor and resting energy expenditure during the acquired immunodeficiency syndrome. Am J Clin Nutr (1993) 1.40
Probability of paternity. Am J Hum Genet (1976) 1.39
[Reactivation of hepatitis B in AIDS]. Presse Med (1995) 1.37
Predictive value of cytomegalovirus viraemia for the occurrence of CMV organ involvement in AIDS. J Med Virol (1990) 1.35
Efficacy of pefloxacin in comparison with erythromycin in the treatment of experimental guinea pig legionellosis. J Antimicrob Chemother (1986) 1.35
Clinical and echocardiographic observations in pulmonary valve endocarditis. Am J Cardiol (1985) 1.33
Intestinal infections in patients with acquired immunodeficiency syndrome. A prospective study in 132 patients. Dig Dis Sci (1989) 1.33
Performance on the dementia rating scale in Parkinson's disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer's disease. J Neurol Neurosurg Psychiatry (2003) 1.31
Lymphoma in patients treated with anti-TNF: results of the 3-year prospective French RATIO registry. Ann Rheum Dis (2009) 1.30
Varicella in patients infected with the human immunodeficiency virus. Arch Dermatol (1990) 1.28
[48, XXXX syndrome in a six year old child. Abnormal transmission of group Xg]. Ann Genet (1968) 1.26
Prevalence of dementia in Chamorros on Guam: relationship to age, gender, education, and APOE. Neurology (2007) 1.22
Effects of zidovudine in 365 consecutive patients with AIDS or AIDS-related complex. Lancet (1988) 1.21
Rate of cognitive change in Alzheimer's disease: methodological approaches using random effects models. J Int Neuropsychol Soc (2001) 1.20
[Plasmodium falciparum: interpretation of the semi-microtest of in vitro chemosensitivity by H3-hypoxanthine incorporation]. Pathol Biol (Paris) (1984) 1.20
French guidelines for diagnosis and treating latent and active tuberculosis in patients with RA treated with TNF blockers. Ann Rheum Dis (2003) 1.18
Cryoglobulins, circulating immune complexes, and complement activation in cerebral malaria. Infect Immun (1981) 1.12
Prevalence of hepatitis C and hepatitis B infection in the HIV-infected population of France, 2004. Euro Surveill (2008) 1.11
[Estimation of probability of paternity from blood groups and genetic markers (author's transl)]. Nouv Rev Fr Hematol (1975) 1.10
Resting energy expenditure is increased in stable, malnourished HIV-infected patients. Am J Clin Nutr (1991) 1.09
Measurement of the electron charge asymmetry in pp[over ]-->W+X-->enu+X events at sqrt[s]=1.96 TeV. Phys Rev Lett (2008) 1.09
Sustained bacteremia in 26 patients with a permanent endocardial pacemaker: assessment of wire removal. Clin Infect Dis (1993) 1.09
Blood groups and genetic markers polymorphism and probability of paternity. Transfusion (1981) 1.08
[Respiratory function and the rheological status of bronchial secretions collected by spontaneous expectoration and after physiotherapy (author's transl)]. Bull Physiopathol Respir (Nancy) (1974) 1.08
Incidence of colonic lesions in Streptococcus bovis and enterococcal endocarditis. Lancet (1987) 1.07
An open study of the pyrimethamine-clindamycin combination in AIDS patients with brain toxoplasmosis. J Infect Dis (1989) 1.07
Pyrimethamine-clarithromycin combination for therapy of acute Toxoplasma encephalitis in patients with AIDS. Antimicrob Agents Chemother (1991) 1.06
Activities of WIN-57273, minocycline, clarithromycin, and 14-hydroxy-clarithromycin against Mycobacterium avium complex in human macrophages. Antimicrob Agents Chemother (1992) 1.06
[Bi-allelic genetic markers and the determination of family relationships]. C R Acad Sci Hebd Seances Acad Sci D (1976) 1.05
Abeta1-42 promotes cholinergic sprouting in patients with AD and Lewy body variant of AD. Neurology (2003) 1.05
Development and assessment of DArT markers in triticale. Theor Appl Genet (2011) 1.05
Resting energy expenditure in human immunodeficiency virus-infected patients: comparison between patients with and without secondary infections. Am J Clin Nutr (1993) 1.05
'Chemical hyperthyroidism': the significance of elevated serum thyroxine levels in L-thyroxine treated individuals. Clin Endocrinol (Oxf) (1985) 1.04
Search for large extra dimensions via single photon plus missing energy final states at sqrt s = 1.96 TeV. Phys Rev Lett (2008) 1.04
Number of deaths among HIV-infected adults in France in 2000, three-source capture-recapture estimation. Epidemiol Infect (2006) 1.02
Clonidine hallucinations. Ann Intern Med (1980) 1.02
Heme requirement and intracellular trafficking in Trypanosoma cruzi epimastigotes. Biochem Biophys Res Commun (2007) 1.00
Culture-negative neutrocytic ascites: a less severe variant of spontaneous bacterial peritonitis. J Hepatol (1990) 1.00
Long-term follow-up of patients with tuberculosis as a complication of tumour necrosis factor (TNF)-alpha antagonist therapy: safe re-initiation of TNF-alpha blockers after appropriate anti-tuberculous treatment. Clin Microbiol Infect (2007) 0.99
Weight related differences in the pharmacokinetics of abacavir in HIV-infected patients. Br J Clin Pharmacol (2005) 0.96
[Accidental and voluntary asphyxiations by coal gas occurring in Paris from 1946 to 1962. Statistical study. Particular influence of the concentration of carbon monoxide and atmospheric conditons]. Presse Med (1968) 0.96
Divided-dose kinetics of mefloquine in man. Br J Clin Pharmacol (1989) 0.96
Plasmodium falciparum: drug sensitivity in vitro of isolates before and after adaptation to continuous culture. Exp Parasitol (1983) 0.95
Ultrastructural and cytochemical changes induced by short and prolonged culture of human monocytes. J Reticuloendothel Soc (1980) 0.95
Efficacy of granulocyte colony-stimulating factor and RU-40555 in combination with clarithromycin against Mycobacterium avium complex infection in C57BL/6 mice. Antimicrob Agents Chemother (1993) 0.95
Expected and observed proportion of subjects excluded from paternity by blood phenotypes of a child and its mother in a sample of 171 families. Am J Hum Genet (1980) 0.94
Search for flavor-changing-neutral-current d meson decays. Phys Rev Lett (2008) 0.94
Partial myeloperoxidase deficiency in a case of preleukaemia. II. Defects of degranulation and abnormal bactericidal activity of blood neutrophils. Br J Haematol (1975) 0.93
Fever of unknown origin in HIV-infected patients: a critical analysis of a retrospective series of 57 cases. J Intern Med (1994) 0.93
[Alzheimer's presenile dementia transmitted in an extended kindred]. Rev Neurol (Paris) (1985) 0.93
Measurement of the lifetime of the Bc+/- meson in the semileptonic decay channel. Phys Rev Lett (2009) 0.92
[Deletion of the short arm of a 13-15 chromosome, hypertelorism and Hp0 haptoglobin phenotype in the same family]. Ann Genet (1966) 0.92
[Systematic study of a median tolerance to a high-fat test diet in hyperlipemia or hyperglyceridemia]. Ann Med Interne (Paris) (1969) 0.91
Measurement of the forward-backward charge asymmetry and extraction of sin2thetaWeff in pp-->Z/gamma* + X-->e+e- +X events produced at sqrt[s] = 1.96 TeV. Phys Rev Lett (2008) 0.91
Activity of doxycycline against preerythrocytic malaria. J Infect Dis (1993) 0.91
Simultaneous but independent activation of adenylate cyclase and glycosylphosphatidylinositol-phospholipase C under stress conditions in Trypanosoma brucei. J Biol Chem (1996) 0.90
Measurement of the inclusive jet cross section in pp[over] collisions at square root [s]=1.96 TeV. Phys Rev Lett (2008) 0.90
Search for long-lived charged massive particles with the D0 detector. Phys Rev Lett (2009) 0.90
HIV combination therapy: immune restitution causing cryptococcal lymphadenitis dramatically improved by anti-inflammatory therapy. Scand J Infect Dis (1998) 0.90
Efficacy of zidovudine in preventing relapses of Salmonella bacteremia in AIDS. J Infect Dis (1991) 0.90
Clarithromycin, minocycline, and rifabutin treatments before and after infection of C57BL/6 mice with Mycobacterium avium. Antimicrob Agents Chemother (1993) 0.88
[ Gene frequencies in 17 polymorphism systems. Study on a sample of subjects living in the Paris region]. Rev Fr Transfus (1974) 0.88
Chemical hyperthyroidism: serum triiodothyronine levels in clinically euthyroid individuals treated with levothyroxine. Arch Intern Med (1982) 0.88
Comparative postantibacterial activities of pefloxacin, ciprofloxacin, and ofloxacin against intracellular multiplication of Legionella pneumophila serogroup 1. Antimicrob Agents Chemother (1990) 0.87
Cloning and sequencing of Plasmodium falciparum DNA fragments containing repetitive regions potentially coding for histidine-rich proteins: identification of two overlapping reading frames. Biochem Biophys Res Commun (1987) 0.87
Mefloquine and an acute brain syndrome. Ann Intern Med (1989) 0.87
Induction and maintenance therapy of cytomegalovirus central nervous system infection in HIV-infected patients. AIDS (2000) 0.87
Response to fluconazole by 23 patients with human immunodeficiency virus infection and oral candidiasis: pharmacological and mycological factors. Antimicrob Agents Chemother (1996) 0.86
[Causes of death among HIV infected adults in French Guyana and the French West Indies in the era of highly active antiretroviral therapy (HAART)]. Med Mal Infect (2004) 0.86
[Phenotypic frequencies of SGPT and C3 fraction of complement in a Parisian population]. Rev Fr Transfus Immunohematol (1977) 0.86
Uveitis due to Leishmania major as part of HAART-induced immune restitution syndrome in a patient with AIDS. Clin Infect Dis (2002) 0.86
Effects of isoproterenol on the pulmonary circulation in obstructive airways disease. Clin Sci (1967) 0.86
[Tuberculosis in patients infected with the human immunodeficiency virus. 30 cases]. Presse Med (1988) 0.86